Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Korean steel producer POSCO ( PKX - Analyst Report ) is on its way to giving Korea its first synthetic natural gas (SNG) plant by the end of year 2013. The company commenced construction of the plant on June 7 at Gwangyang Steelworks.
POSCO E&C will be responsible for the construction of the SNG plant with an annual production capacity of 500,000 tons. The plant, which is going to be a secured source of energy for the region, will be constructed using environment friendly technologies.
Synthetic natural gas is a new alternative to Liquid Natural Gas (LNG), prepared by gasifying low-cost coal at high pressure and temperature and, subsequently, purified. This product, serving as a welcome substitute, opens up new avenue to restrict annual import of LNG worth KRW 200 billion in Korea.
We believe that POSCO’s relentless focus on regional diversification, self-sufficiency in raw materials and higher proportion of value-added products in its product mix are all encouraging attributes.
For fiscal year 2011, management increased its revenue and sales target due to new facility additions and full capacity operations. Consolidated revenue is expected to be approximately KRW 67.8 trillion compared with KRW 66 trillion expected earlier.
POSCO is the world’s third largest steelmaker on the basis of output. The company primarily manufactures steel for the shipping and construction industries and operates through its two steel production facilities, the Pohang Works and the Gwangyang Works.
Rising competition and higher raw material costs, however, are factors that cause a great deal of worry. The company faces stiff competition from Arcelor Mittal ( MT - Analyst Report ) and Nippon Steel Corp.
We currently maintain a Neutral recommendation on the stock.
Read the full reports :
Analyst Report on PKX
Analyst Report on MT